ProfileGDS4718 / 202534_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 85% 82% 88% 88% 94% 95% 88% 86% 91% 85% 88% 93% 90% 92% 91% 88% 84% 92% 89% 89% 89% 88% 88% 92% 89% 87% 90% 87% 92% 92% 92% 85% 82% 90% 91% 90% 82% 89% 80% 88% 92% 81% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9520388
GSM549102patient 115, normal, homogenized [OPG study]8.3642785
GSM549104patient 119, normal, homogenized [OPG study]8.1598282
GSM549108patient 138, normal, homogenized [OPG study]8.7558788
GSM549119patient 077, normal, homogenized [OPG study]8.8009588
GSM549133patient 032, cancer, homogenized [OPG study]10.012694
GSM549139patient 042, cancer, homogenized [OPG study]10.252195
GSM549099patient 107, normal, homogenized [OPG study]8.8388
GSM549109patient 139, normal, homogenized [OPG study]8.5951286
GSM549110patient 046, normal, homogenized [OPG study]9.4411191
GSM549114patient 063, normal, homogenized [OPG study]8.5625685
GSM549122patient 082, normal, homogenized [OPG study]8.8873888
GSM549134patient 033, cancer, homogenized [OPG study]9.7579693
GSM549136patient 036, cancer, homogenized [OPG study]9.3274190
GSM549140patient 044, cancer, homogenized [OPG study]9.5441592
GSM549111patient 047, normal, homogenized [OPG study]9.4389791
GSM549113patient 057, normal, homogenized [OPG study]9.0869788
GSM549132patient 031, cancer, homogenized [OPG study]8.3877484
GSM549137patient 038, cancer, homogenized [OPG study]9.5687892
GSM549142patient 047, cancer, homogenized [OPG study]8.5519189
GSM549100patient 110, normal, homogenized [OPG study]8.9781189
GSM549107patient 135, normal, homogenized [OPG study]9.1080189
GSM549115patient 068, normal, homogenized [OPG study]9.1375588
GSM549116patient 072, normal, homogenized [OPG study]9.0011488
GSM549120patient 078, normal, homogenized [OPG study]9.599792
GSM549131patient 030, cancer, homogenized [OPG study]9.0506289
GSM549118patient 074, normal, homogenized [OPG study]8.8087687
GSM549129patient 027, cancer, homogenized [OPG study]9.1409190
GSM549123patient 088, normal, homogenized [OPG study]8.7808987
GSM549124patient 006, cancer, homogenized [OPG study]9.4275292
GSM549126patient 015, cancer, homogenized [OPG study]9.4608892
GSM549128patient 025, cancer, homogenized [OPG study]9.5444992
GSM549103patient 117, normal, homogenized [OPG study]8.2773285
GSM549117patient 073, normal, homogenized [OPG study]8.1089482
GSM549138patient 041, cancer, homogenized [OPG study]9.1979390
GSM549141patient 045, cancer, homogenized [OPG study]9.4449591
GSM549130patient 028, cancer, homogenized [OPG study]9.1570990
GSM549101patient 111, normal, homogenized [OPG study]8.0953282
GSM549105patient 128, normal, homogenized [OPG study]8.9714589
GSM549106patient 134, normal, homogenized [OPG study]8.0473580
GSM549112patient 048, normal, homogenized [OPG study]8.9834288
GSM549125patient 011, cancer, homogenized [OPG study]9.542792
GSM549127patient 024, cancer, homogenized [OPG study]7.9733481
GSM549135patient 035, cancer, homogenized [OPG study]9.3077290